Last Updated 16 Nov 2026

Preliminary data analysis

An exploratory comparison of de-identified Oligoscan and Theriome Aristotle Plus results. The aim is to examine shared marker patterns, differences between examples, and their coherence with proposed biochemical mechanisms.

This analysis describes twenty selected report pairs. Assessing causes, tissue deficiency or enzyme activity requires additional clinical and experimental evidence.

Patterns in data

Each example pairs one Oligoscan report with one Theriome Aristotle Plus report. Nineteen Theriome reports were supplied as PDFs. Example 4 was an early vendor-supplied CSV. The prepared data contain 42 direct Oligoscan rows and 296 direct Theriome analyte rows per example: 6,760 direct observations in total, with three unavailable numerical scores. A further 464 inferred cofactor scores are available separately.

Aluminium - all twenty Oligoscan tool outputs flag aluminium as elevated. Scores range from 44.1 in Example 17 to 80.2 in Example 19. These values use the tool’s metal scoring scale.

Silicon - all twenty Oligoscan outputs flag silicon as Low, with deviation scores from -47.6% to -25.2%. More negative silicon scores tend to accompany higher aluminium scores: Spearman rank correlation -0.70 across these twenty reports.

Magnesium and ATP - all twenty Oligoscan outputs label magnesium low. Sixteen Theriome outputs flag ATP as IR-LOW, Examples 7 and 18 flag it HIGH, Example 13 flags it IR-HIGH, and Example 10 has no ATP status flag.

NAD reference profiles - in all nineteen PDF reports, NADP is closer to its reference centre than NAD, while NADPH is further below its reference centre. This pattern recurs across the nineteen sets of source scores.

Example 4 - reported use of sublingual NAD+ and NAG adds potential confounding to its NAD and sugar-metabolite profile. Its CSV scoring method also differs from the PDF reports. These factors limit interpretation of its contrast with the other examples. A replacement PDF from the same original specimen has been requested to clarify the reporting-format difference. Supplement exposure remains relevant to interpretation.

The direct-marker comparison uses reported analyte rows. The tools’ inferred NAD, NADP, NADPH and ATP deficiency scores are available separately in the explorer. These derived scores depend on the observations used to calculate them.

For more on the potential causes and impact of these patterns, see remineralisation and toxic metals.

Patterns across all twenty examples

These groups use the direct report rows from all twenty pairs, including the updated Example 4 CSV scores. Counts retain the full twenty-example denominator. Inferred cofactor scores are separate; missing or unflagged results do not count as low or high.

Frequent low flags in Theriome reports

At the 50% inclusion threshold, 109 direct analytes carry a LOW or IR-LOW flag in at least 10 of the 20 reports. Seventeen carry these flags in every report. NADPH is flagged LOW in nineteen reports and IR-LOW in one. Missing or unflagged results remain in the denominator.

Theriome markerLOWIR-LOWCombined
2-Furoic acid01010/20 (50%)
2-Ketobutyric acid01111/20 (55%)
3-Aminobutyric acid01515/20 (75%)
3-hydroxykynurenine02020/20 (100%)
3-Indoleacetic acid01010/20 (50%)
3-Indolepropionic acid01818/20 (90%)
3-Methyl-2-oxovaleric acid8917/20 (85%)
3-Nitrotyrosine11415/20 (75%)
4-Ethylbenzoic acid10313/20 (65%)
4-Hydroxybenzaldehyde61420/20 (100%)
4-Imidazoleacetic acid01717/20 (85%)
4-Methoxyphenylacetic acid01010/20 (50%)
4-Pyridoxic acid02020/20 (100%)
5-Hydroxytryptophan02020/20 (100%)
5-Methylcytidine01111/20 (55%)
6-Hydroxynicotinic acid01111/20 (55%)
Acetylcarnitine01919/20 (95%)
Adenine01414/20 (70%)
Adenosyl-L-homocysteine01212/20 (60%)
Adipic acid11011/20 (55%)
Adonitol01717/20 (85%)
ADP ribose01313/20 (65%)
AMP01919/20 (95%)
Arginine01111/20 (55%)
Asparagine1910/20 (50%)
Aspartate11011/20 (55%)
ATP01616/20 (80%)
Benzoic acid01919/20 (95%)
Betaine11920/20 (100%)
Biotin11920/20 (100%)
cADPR61319/20 (95%)
Caffeine01212/20 (60%)
Capric acid11415/20 (75%)
Caprylic acid02020/20 (100%)
Carnitine01616/20 (80%)
Carnosine01111/20 (55%)
Choline1910/20 (50%)
Citraconic acid01111/20 (55%)
Citrulline2810/20 (50%)
Creatine01414/20 (70%)
Creatinine01313/20 (65%)
D-Galacturonic acid01212/20 (60%)
D-Ribose 5-phosphate01111/20 (55%)
dUTP11213/20 (65%)
Fructose 1,6-bisphosphate61319/20 (95%)
gamma-Aminobutyric acid01616/20 (80%)
GDP01616/20 (80%)
Gentisic acid01212/20 (60%)
Glucose6612/20 (60%)
Glucose 1-phosphate11011/20 (55%)
Glutamine7411/20 (55%)
Glycocyamine01818/20 (90%)
Heptadecanoic acid4711/20 (55%)
Hexanoic acid01919/20 (95%)
Hypoxanthine01111/20 (55%)
Imidazole01313/20 (65%)
Isobutyryl-CoA01313/20 (65%)
Isoleucine2911/20 (55%)
Itaconic acid11516/20 (80%)
Ketoleucine01212/20 (60%)
Kynurenine02020/20 (100%)
L-2-Hydroxyglutaric acid61319/20 (95%)
L-Arabitol01919/20 (95%)
Lactate9514/20 (70%)
Lauric acid02020/20 (100%)
Leucic acid01414/20 (70%)
Leucine4913/20 (65%)
m-Coumaric acid01818/20 (90%)
Malic acid01212/20 (60%)
Melatonin01111/20 (55%)
Methionine02020/20 (100%)
Methyl alpha-D-galactopyranoside01111/20 (55%)
Methylguanidine01111/20 (55%)
Methylmalonic acid01111/20 (55%)
Myristic acid01919/20 (95%)
N-Acetyl-D-galactosamine51318/20 (90%)
N,N-Dicyclohexylurea18119/20 (95%)
NAD01919/20 (95%)
NADH01414/20 (70%)
NADPH19120/20 (100%)
Neopterin1910/20 (50%)
Nicotinamide01111/20 (55%)
Nonadecanoic acid4812/20 (60%)
Normetanephrine01111/20 (55%)
Ornithine01010/20 (50%)
p-Coumaric acid01414/20 (70%)
Palmitic acid01919/20 (95%)
Pentadecanoic acid61218/20 (90%)
Phenylacetic acid01919/20 (95%)
Phenylalanine01212/20 (60%)
Phenylbutazone02020/20 (100%)
Phenylglyoxylic acid41014/20 (70%)
Phenylpyruvic acid01010/20 (50%)
Phosphocreatine01919/20 (95%)
Phthalic acid01010/20 (50%)
pregnenolone sulfate02020/20 (100%)
Propranolol01010/20 (50%)
SAICAR61420/20 (100%)
Spermidine01414/20 (70%)
Stearic Acid01919/20 (95%)
Succinic acid01212/20 (60%)
Tryptophan01010/20 (50%)
Uracil01616/20 (80%)
Uridine02020/20 (100%)
Uridine diphosphate-N-acetylglucosamine01818/20 (90%)
Valeric acid31013/20 (65%)
Vitamin D361420/20 (100%)
Xanthine01010/20 (50%)
Xylitol02020/20 (100%)

Frequent low flags in Oligoscan reports

At the 50% inclusion threshold, twenty Oligoscan markers carry Low or IR-LOW flags in at least 10 of the 20 reports.

Oligoscan markerLowIR-LOWCombined
Chromium (Cr)18220/20 (100%)
Cobalt (Co)61016/20 (80%)
Copper (Cu)71219/20 (95%)
Fluor (F)15520/20 (100%)
Iodine (I)13215/20 (75%)
Lithium (Li)14519/20 (95%)
Magnesium (Mg)20020/20 (100%)
Manganese (Mn)11920/20 (100%)
Molybdenum (Mo)16319/20 (95%)
Phosphorus (P)15419/20 (95%)
Potassium (K)10616/20 (80%)
Selenium (Se)11011/20 (55%)
Silicon (Si)20020/20 (100%)
Sulphur (S)10717/20 (85%)
Vanadium (V)16420/20 (100%)
Vitamin B661016/20 (80%)
Vitamin B9 (Folic acid)8614/20 (70%)
Vitamin B125611/20 (55%)
Vitamin D71219/20 (95%)
Zinc (Zn)13417/20 (85%)

Frequent high flags in Theriome reports

No Theriome analyte carries a HIGH or IR-HIGH flag in all twenty examples. The eight most frequent are shown below; glycine has the highest count at seventeen of twenty.

Theriome markerHIGHIR-HIGHCombined
3-Methyladipic acid13114/20 (70%)
Fructose14115/20 (75%)
Glutamic acid12113/20 (65%)
Glycine13417/20 (85%)
Homoserine11415/20 (75%)
Mannose 6-phosphate11112/20 (60%)
Pyruvate10313/20 (65%)
Threonine12416/20 (80%)

Elevated metals in every Oligoscan report

Aluminium, cadmium, lead, silver and tin are flagged elevated in all twenty reports. Oligoscan’s High, High+ and EXCESS categories are retained separately.

Oligoscan markerHighHigh+EXCESS
Aluminium (Al)2153
Cadmium (Cd)6131
Lead (Pb)1721
Silver (Ag)7112
Tin (Sn)1640

Scores at or beyond -50 and +50

Twenty-three direct Theriome analytes have a displayed score of -50 or lower, or +50 or higher, in every example. There are no scores strictly between -50 and +50 for these analytes, and all twenty scores are available for each.

The boundaries are included. For the nineteen PDF reports, -50 and +50 correspond to z-scores of -0.5 and +0.5 because the displayed score is z multiplied by 100. Example 4 uses a CSV reference-deviation percentage. The threshold groups use these displayed scores; their numerical scales differ.

Six analytes with both directions

Theriome marker-50 or lower+50 or higher
Glutamic acid713
Myristic acid191
Palmitic acid191
Pentadecanoic acid182
Phenylacetic acid191
Stearic Acid191

Example 4 is the sole positive result for myristic, palmitic, phenylacetic and stearic acids. Pentadecanoic acid is positive in Examples 4 and 8. Within the nineteen PDF reports alone, glutamic acid remains mixed at seven below and twelve above the thresholds, as does pentadecanoic acid at eighteen below and one above.

Seventeen analytes consistently at -50 or lower

Seventeen analytes have displayed scores of -50 or lower in every example: 3-hydroxykynurenine, 4-hydroxybenzaldehyde, 4-pyridoxic acid, 5-hydroxytryptophan, betaine, biotin, caprylic acid, kynurenine, lauric acid, methionine, NADPH, phenylbutazone, pregnenolone sulfate, SAICAR, uridine, vitamin D3 and xylitol.

Uridine is exactly -50 in Examples 6 and 7; pregnenolone sulfate is exactly -50 in Examples 6 and 18. All their other scores are below -50. No direct Theriome analyte is consistently at +50 or higher.

Additional relationships and exceptions

Unless stated otherwise, these details refer to the nineteen Theriome PDF reports. Low flags combine LOW and IR-LOW; high flags combine HIGH and IR-HIGH.

PDF score ranges - among the consistently low analytes listed above, biotin ranges from -0.81 to -0.53 z; 5-hydroxytryptophan from -0.74 to -0.58 z; betaine from -0.81 to -0.62 z; and methionine from -0.75 to -0.54 z.

Fructose and fructose 1,6-bisphosphate - high fructose and low fructose 1,6-bisphosphate occur together in fourteen of nineteen reports. For fructose, Example 20 is IR-LOW at -0.59 z; Examples 12, 13 and 17 are unflagged. Examples 12, 13 and 20 have scores below the reference centre. Fructose 1,6-bisphosphate carries low flags in eighteen reports; Example 7 is unflagged at +0.40 z.

N-Acetyl-D-galactosamine - all nineteen PDF scores are below the reference centre, with low flags in eighteen reports. Example 14 is unflagged, with a z-score of -0.49.

Uridine diphosphate-N-acetylglucosamine - all nineteen PDF scores are below the reference centre, with low flags in seventeen reports. Examples 12 and 17 are unflagged, at -0.46 and -0.45 z respectively. This marker and N-acetyl-D-galactosamine both carry low flags in sixteen of nineteen reports.

Mannose 6-phosphate - the low-flag exceptions are Examples 6, 16 and 20. Examples 8, 12, 14 and 18 are unflagged.

Glutamic acid and GABA - high glutamic acid and low GABA flags occur together in ten of nineteen reports. All nineteen gamma-aminobutyric acid (GABA) scores are below the reference centre, ranging from -0.81 to -0.19 z. Fifteen reports carry an IR-LOW flag; Examples 11, 12, 15 and 20 are unflagged. The low-glutamic-acid reports are Examples 1, 3, 9, 12, 14, 18 and 20.

Creatine - all nineteen PDF scores are below the reference centre, ranging from -0.77 to -0.15 z, with a median of -0.59. Fourteen reports carry an IR-LOW flag; Examples 6, 8, 11, 14 and 17 are unflagged.

Phosphocreatine - all nineteen PDF scores are below the reference centre, ranging from -0.67 to -0.49 z. Eighteen reports carry an IR-LOW flag; Example 13 is unflagged at -0.49 z. Creatine and phosphocreatine show a shared downward pattern. Establishing impaired synthesis requires additional evidence.

Example 4’s CSV flags GABA low. Creatine is flagged HIGH at +290.1% on its CSV reference-based scale; phosphocreatine is IR-LOW at -71.8%. Its low fructose and high N-acetyl-D-galactosamine contrast with the predominant PDF directions. Its different scoring method and reported supplement exposure remain relevant.

Urea-cycle-related markers

Arginine, citrulline, ornithine, aspartate and fumarate participate in the urea cycle. Their direct scores in the nineteen PDF reports show the following patterns.

Arginine and citrulline - arginine carries low flags in ten of nineteen PDF reports; citrulline in nine. Arginine scores are below the reference centre in seventeen reports; Example 15 is HIGH at +1.40 z, and eight reports are unflagged, including Example 18 at +0.45 z. Citrulline scores are below the reference centre in fifteen reports; Examples 14 and 18 are IR-HIGH at +0.77 and +0.79 z respectively. Eight reports are unflagged, including Example 6 at +0.20 z and Example 20 at +0.11 z.

Ornithine and aspartate - ornithine carries an IR-LOW flag in nine of nineteen PDF reports, with ten unflagged results and no high flags. Thirteen scores are below the reference centre, five above it and one at zero. Aspartate carries an IR-LOW flag in ten reports. It has fourteen scores below the reference centre, eight unflagged results and an IR-HIGH flag in Example 16 at +0.89 z.

Fumaric acid - sixteen PDF reports are unflagged. Examples 6 and 16 carry IR-HIGH flags and Example 7 is HIGH. Twelve scores are below the reference centre, with no low flags.

Example 4’s CSV flags arginine, citrulline, ornithine and aspartate low; fumaric acid is unflagged. Urea, ammonia and argininosuccinate are absent from the prepared dataset. Assessing urea-cycle flux or ammonia clearance requires additional measurements and clinical context.

Explore the paired data

Follow an example’s NAD pathway profile, inspect individual markers and their peaks or troughs, compare grouped heatmaps, or choose two markers to view side by side across all twenty examples. Marker summaries are calculated within their source scoring group, with separate summaries for CSV and PDF direct scores.

Data analysis controls

Direct report values and inferred scores stay separate. Example 4 uses a different Theriome scoring method.

Loading de-identified example data...

NADP formation and redox handling

NAD kinase phosphorylates NAD+ to NADP+ using ATP. Magnesium-dependent activity has been demonstrated in human NAD kinase preparations. A distinct mitochondrial NAD kinase also exists. These findings provide a biochemical basis for examining magnesium, ATP, NAD and NADP together. Williams and Jones, 1985; Ohashi and colleagues, 2012.

Two questions guide this comparison: whether the marker pattern is compatible with constraints on NADP formation, and whether NADP/NADPH findings are compatible with altered reduction or consumption. Both require several markers and relevant clinical context. NADPH metabolism is compartmentalised; resolving cytosolic and mitochondrial processes requires compartment-specific methods. Lewis and colleagues, 2014.

Examples 7 and 18 combine high ATP with low Oligoscan magnesium. Example 8 combines IR-LOW ATP with a NADP score of -0.11 z. These combinations help assess how well a proposed explanation accommodates variation across the examples.

Estimating NADPH:NADP concentration ratios, total NADP/NADPH pool size or NAD kinase activity requires suitable measurements, units and assay calibration. These inputs are unavailable in the prepared data.

Silicon and aluminium

Low silicon and elevated aluminium co-occur across all twenty Oligoscan reports. The inverse rank association describes variation within this selected set of tool scores. Exposure history, diet, assay behaviour and other shared influences could contribute to it.

Silica chemistry provides a reason to examine these markers together. In a tracer study of three healthy volunteers, oligomeric silica reduced gastrointestinal aluminium uptake. The monomeric form showed no significant effect under the study conditions. Jugdaohsingh and colleagues, 2000.

Those findings concern chemical form and gut absorption. Applying this mechanism to the report pattern requires information about exposure, silicon form and independent measurements of aluminium handling. Both scores here come from the same Oligoscan report, so their association also requires validation with independent measurements.

Common patterns described in MPO

The following proposed patterns and mechanisms form the working interpretation framework for the Metabolic Pathway Overlay examples. Each requires assessment against the individual reports and supporting evidence. Mechanism-specific scoring is a future analysis step.

  1. Elevated toxic metals, with mineral and electrolyte deficiencies.
  2. A reduced total NADP/NADPH pool and impaired conversion of NADP to NADPH (low NADPH), with potentially broad effects. The reported exception is where aluminium is not elevated.
  3. Constraints on glycolysis and glycogen synthesis.
  4. Altered pyruvate and/or lactate levels.
  5. Constraints on the pentose phosphate pathway and downstream PRPP synthesis.
  6. Impairments in purine and pyrimidine metabolism.
  7. Oxidative stress.
  8. TCA cycle alterations and constraints.
  9. Issues with NAD+ synthesis and redox balance.
  10. Reduced carnitine synthesis and associated carnitine-shuttle constraints.
  11. Elevated glutamate relative to low GABA, except where severe malnutrition constrains glutamate synthesis.
  12. Issues with glutathione metabolism.
  13. Issues involving magnesium and Mg-ATP.
  14. Urea-cycle and nitric oxide synthase impairments, with potential effects on vascular tone.
  15. Dysregulated neurotransmitter synthesis and degradation.
  16. Impaired conversion of choline to betaine.
  17. Impaired methylation and associated SAMe, glycine, and cysteine metabolism.
  18. Impaired creatine synthesis.

Testing the exception in pattern 2 requires a comparison group with non-elevated aluminium; all twenty examples here have elevated aluminium scores. Assessing the malnutrition exception in pattern 11 requires clinical nutritional information, which is unavailable. The proposed changes in pool size, pathway flux and enzyme activity also require further investigation.

How to read the scores

Theriome PDFs - the displayed score is the source z-score multiplied by 100, consistent with MPO’s numerical convention. For example, -168 means z = -1.68, or 1.68 standard deviations below the reference centre. This explorer has its own labelled heatmap colour scale.

Example 4 CSV - deviation scores are calculated from the original relative-abundance values using the reference ranges supplied by Universal OAT 0.1.55. The CSV contains no reference bounds. Reprocessing with the updated reference table changed 289 scores and 71 status flags; the original measured values are unchanged. These scores are summarised separately from the PDF z-scores.

Oligoscan - mineral deviation scores, vitamin percentages and metal scores retain their source meanings. Each scale requires its own interpretation.

Inferred cofactors - rules applied to report observations generate these visual scores. Their clinical significance requires independent validation. Missing inferred rows remain unreported.

Missing data - unavailable scores appear as NA. Blank source status flags remain blank. Both retain an unspecified status in the comparison.

Limits of this comparison

The dataset contains twenty selected pairs and lacks a healthy control group. Its population relevance is unknown. Collection dates, the interval between paired tests, specimen details, units and most clinical context are unavailable in the prepared data. Example 4 has reported exposure to sublingual NAD+ and NAG; doses and timing are not recorded here. Supplement use in the other examples is unspecified. Tissue and biochemical compartment differences remain unresolved.

All twenty pairs were reprocessed on 16 November 2026 using Oligoscan 1.7.4 and Universal OAT 0.1.55, with one frozen set of parser and rule assets. All Oligoscan results and all nineteen PDF direct scores and flags are unchanged from the previous dataset. Inferred cofactor scores use the current rules. Parser versions are retained in the downloads. The newer pathway interpretations are available in MPO.

There are many markers relative to the number of examples. Apparent correlations may be sensitive to individual cases, scoring conventions, selection and shared reference distributions. Analysis is limited to descriptive summaries. A direct-row label records the parser’s classification; assay validity requires separate evaluation.

Pending

Resolve Example 4 - compare the replacement PDF with the retained vendor CSV from the same specimen, and review the timing and doses of the reported NAD+ and NAG use when interpreting its profile.

Describe marker coherence - compare direction, magnitude and variability within compatible scoring groups, retaining all exceptions and denominators.

Mechanism map and references - MPO already provides much of the mechanism mapping. A supporting table of references is in progress.

Assess concordance - show supporting observations, contradictions and missing evidence. Report mechanistic evidence, measurement relevance, coverage and sensitivity to individual examples separately.

The downloadable CSV and JSON contain the prepared de-identified observations, source scores and marker identities for future analyses.